HOME > TOP > Introdusing our Business > Drug Development Support

Drug Development Support

From the measurement of genetic biomarkers in each phase of drug development to the development, application for regulatory manufacture, and marketing of in vitro diagnostic reagents including companion diagnostic reagents, we will deal with the situation in one stop.

Drug Development Support
※1Research and Development
We propose and develop Assays suitable for biomarker detection from a wide perspectives.
  • Liquid Biopsy sample 、tissue sample are availble
  • NGS 、nCounter 、digital PCR 、high sensitivity PCR using BNA
※2Clinical development
Operation would be available according to CAP/CLIA criteria, RG Quality Assurance Standards, etc.
※3Pharmaceutical affairs application / insurance application
Staff with extensive experiences with gene-related IVD applications will work on that.


RikenGenesis provides a variety of services appropriate for each phase of drug development.

We would like to measure the genes associated with our drug pipeline. Are there any good methods?

  • We would like to comprehensively analyze the genetic mutation concerning the development pipeline.
  • We would like to analyze the hot spot mutation of the cancer comprehensively.
  • We would like to analyze the gene abnormality using liquid biopsy.
  • We would like to analyze genes related to cancer immunity.

RikenGenesis investigates trends and propose an assay system that is suitable for your analysis.

  • Genetic Analysis Using Next-Generation Sequences (NGS)
  • CfDNA NGS analysis
  • Exhaustive Cancer gene mapping

You want to measurement a biomarker, but do not have a system.

  • We would like to include a genetic measurement targeted liquid biopsy in a clinical trial.
  • We wanted to expression analysis of particular genes in FFPE samples stored for a long time.

RikenGeesis is available seamlessly from construction of measurement system to measurement.

  • RikenGenesis provides service for construction of a measurment system to clinical trials (NGS, dPCR)
  • Expression analysis using nCounter custom panels

Is it possible to develop a gene measurement system constructed in a clinical trial as a companion diagnostic agent?

We are involved in the evaluation of assay systems, setting-up of clinical performance tests, preparation of submission manufactures for companion diagnostic reagents, application for approval, and marketing.

  • List of In Vitro Diagnostic Reagents Approved on We

I would like to introduce overseas approved diagnostic agents into the Japanese market.

RikenGenesis supports as Marketing Auholication Holder (MAH) or the Designated Marketing Auholication Holder (DMAH) of in vitro diagnostics.

  • Support Details




Contact us